ENDONOVO THERAPEUTICS, INC. Accounts Payable
ENDONOVO THERAPEUTICS, INC. (ENDV) had Accounts Payable of $884.20 thousand as of 2022-12-31, per its 10-K filed 2023-04-17.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2023-04-17
- 2022-12-31: Accounts Payable, Current $884.20K.
- 2022-09-30: Accounts Payable, Current $865.75K.
- 2022-06-30: Accounts Payable, Current $786.03K.
- 2022-03-31: Accounts Payable, Current $704.02K.
| Period end | Accounts Payable, Current |
|---|---|
| 2022-12-31 | $884.20K 10-K · filed 2023-04-17 |
| 2022-09-30 | $865.75K 10-Q · filed 2022-11-21 |
| 2022-06-30 | $786.03K 10-Q · filed 2022-08-22 |
| 2022-03-31 | $704.02K 10-Q · filed 2022-05-19 |
| 2021-12-31 | $658.46K 10-K · filed 2023-04-17 |
| 2021-09-30 | $753.04K 10-Q · filed 2021-11-19 |
| 2021-06-30 | $711.24K 10-Q · filed 2021-08-23 |
| 2021-03-31 | $721.84K 10-Q · filed 2021-05-24 |
| 2020-12-31 | $700.93K 10-K · filed 2022-04-14 |
| 2020-09-30 | $762.17K 10-Q · filed 2020-11-19 |
| 2020-06-30 | $609.41K 10-Q · filed 2020-08-19 |
| 2020-03-31 | $576.74K 10-Q · filed 2020-06-12 |
| 2019-12-31 | $599.47K 10-K · filed 2021-04-13 |
| 2019-09-30 | $346.18K 10-Q · filed 2019-11-19 |
| 2019-06-30 | $280.99K 10-Q · filed 2019-08-13 |
| 2019-03-31 | $198.88K 10-Q · filed 2019-05-09 |
| 2018-12-31 | $157.39K 10-K · filed 2020-05-04 |
| 2017-12-31 | $143.96K 10-K · filed 2019-04-15 |
| 2011-12-31 | $745.00 10-K · filed 2012-04-13 |
| 2010-12-31 | $1.90K 10-K · filed 2012-04-13 |